8-K: cbdMD, Inc. Grants Restricted Stock Units and Approves Annual Fees for Independent Directors

cbdMD, Inc. granted restricted stock units to independent and non-management employee directors and approved annual fees for independent directors on May 16, 2025.

Summary

• On May 16, 2025, cbdMD, Inc.'s board of directors issued 1,572 restricted stock units (RSUs) to each independent director and the non-management employee director as compensation for their services.
• These RSUs are for the term beginning on April 11, 2025, and will vest quarterly on June 30, 2025, September 30, 2025, December 31, 2025, and March 31, 2026.
• The RSUs were granted under the company's 2015 and 2021 Equity Compensation Plan.
• The amount of restricted common stock issued will be based on the closing price of the common stock as reported by the NYSE American LLC on May 16, 2025.
• The board also approved annual fees for the independent directors, including a $35,000 annual cash retainer payable monthly.
• Additional compensation includes $26,500 for the Chairman of the Board, $17,000 for the Chairman of the Audit Committee, and $7,000 for the Chairman of the Compensation, Corporate Governance and Nominating Committee.
• Audit Committee members (excluding the chairperson) will receive an additional $8,500, and Compensation, Corporate Governance and Nominating Committee members (excluding the chairperson) will receive an additional $4,000.

Sentiment

Score: 7

Explanation: The announcement is fairly neutral, detailing standard corporate governance practices related to director compensation. It reflects a stable and ongoing business operation.

Positives

• The grant of RSUs and approval of annual fees demonstrate cbdMD's commitment to compensating its independent directors and non-management employee director.
• The quarterly vesting schedule of the RSUs aligns director compensation with the company's performance over time.
• The additional compensation for committee chairs and members recognizes their increased responsibilities and contributions.

Industry Context

Director compensation is a standard practice for publicly traded companies to attract and retain qualified individuals to oversee the company's strategy and operations; the specific amounts and forms of compensation (cash, stock options, restricted stock) vary based on company size, industry, and performance.

Comparison to Industry Standards

• Director compensation packages vary widely across industries and company sizes.
• Comparing cbdMD's director compensation to similar-sized companies in the consumer goods or cannabis industries would provide a more accurate benchmark.
• Companies like Canopy Growth Corporation or Cronos Group could be considered for comparison, although their financial performance and market capitalization may differ significantly.

Stakeholder Impact

• Shareholders may view the director compensation as an investment in good governance.
• Directors are incentivized to act in the best interests of the company through the grant of RSUs.
• Employees may see this as a sign of stability and commitment to leadership.

Key Dates

Keywords

cbdMD, restricted stock units, RSUs, independent directors, compensation, annual fees, corporate governance, equity compensation plan